CCI Update:
Q2043 Edit Changes Promise Simpler Administration Reporting
Published on Fri Apr 13, 2012
If your claims fell victim to these erroneous bundles, now's the time to resubmit.Staying up to date on Provenge coding rules certainly keeps you on your toes. First, Medicare said you couldn't report an administration code with Provenge code Q2043 (Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion). Then, even after CMS changed that rule, a Correct Coding Initiative (CCI) edit bundled certain administration codes into Q2043. Good news: Your claims for this prostate cancer therapy should have smoother sailing now that CCI has implemented much needed edit deletions for physicians. Take Advantage of Retroactive DeletionCCI version 18.1, effective April 1, 2012, deletes edits bundling the following codes into Q2043: 96360, Intravenous infusion, hydration; initial, 31 minutes to 1 hour 96365, Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour 96372, [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
